Aadi Bioscience COO Brendan Delaney receives $5.7M in 2021
Aadi Bioscience reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Aadi Bioscience reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, four executives at Aadi Bioscience received on average a compensation package of $3.8M, a 370% increase compared to previous year.
Brendan Delaney, Chief Operating Officer, received $5.7M in total. 96% of Delaney's compensation, or $5.5M, was in option awards. Delaney also received $82K in non-equity incentive plan and $137K in salary.
Scott Giacobello, Chief Financial Officer, received a compensation package of $4.1M. 97% of the compensation package, or $4M, was in option awards.
Neil Desai, Chief Executive Officer, earned $3.7M in 2021.
Joseph Gardner, Former President and Principal Executive Officer, received $1.5M in 2021, which increases by 89% compared to 2020.